CHAM
MRNA icon

Clear Harbor Asset Management’s Moderna MRNA Stock Holding History

Clear Harbor Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,948
Closed -$350K – 389
2024
Q2 		$350K Hold
2,948
– – 0.03% 267
2024
Q1 		$314K Buy
2,948
+223
+8% +$22.5K 0.03% 286
2023
Q4 		$271K Hold
2,725
– – 0.02% 293
2023
Q3 		$281K Buy
+2,725
New +$304K 0.03% 276
2023
Q1 		– Sell
-1,125
Closed -$202K – 415
2022
Q4 		$202K Buy
+1,125
New +$184K 0.03% 316
2022
Q2 		– Sell
-1,185
Closed -$204K – 433
2022
Q1 		$204K Hold
1,185
– – 0.02% 343
2021
Q4 		$301K Buy
1,185
+25
+2% +$7.31K 0.03% 300
2021
Q3 		$446K Sell
1,160
-30
-3% -$11.1K 0.01% 244
2021
Q2 		$280K Buy
+1,190
New +$213K 0.03% 291
2020
Q4 		– Sell
-1,215
Closed -$86K – 574
2020
Q3 		$86K Buy
+1,215
New +$84.7K 0.01% 332

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clear Harbor Asset Management's MRNA Position: Q3 2024 in Review

Clear Harbor Asset Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,948 shares — an estimated $350K sold.

Clear Harbor Asset Management first reported a position in MRNA in Q3 2020 and held it in 10 quarters. The position peaked at $446K in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Clear Harbor Asset Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Clear Harbor Asset Management sold 2,948 Moderna shares in Q3 2024, an estimated $350K.
  • Clear Harbor Asset Management first reported a position in Moderna in Q3 2020 and held it in 10 quarters.
  • Clear Harbor Asset Management's Moderna position peaked at $446K in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Clear Harbor Asset Management's 13F filing for Q3 2024, filed 24 Oct 2024.